Return On Assets of Moleculin Biotech, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Moleculin Biotech, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Moleculin Biotech, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -257%, a 155% decline year-over-year.
  • Moleculin Biotech, Inc. annual Return On Assets for 2024 was -90%, a 33% decline from 2023.
  • Moleculin Biotech, Inc. annual Return On Assets for 2023 was -68%, a 60% decline from 2022.
  • Moleculin Biotech, Inc. annual Return On Assets for 2022 was -42%, a 143% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Moleculin Biotech, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -257% -157% -155% 01 Jul 2025 30 Sep 2025
Q2 2025 -159% -75% -89% 01 Apr 2025 30 Jun 2025
Q1 2025 -98% -25% -35% 01 Jan 2025 31 Mar 2025
Q4 2024 -90% -22% -33% 01 Oct 2024 31 Dec 2024
Q3 2024 -101% -47% -87% 01 Jul 2024 30 Sep 2024
Q2 2024 -84% -31% -59% 01 Apr 2024 30 Jun 2024
Q1 2024 -73% -24% -49% 01 Jan 2024 31 Mar 2024
Q4 2023 -68% -25% -60% 01 Oct 2023 31 Dec 2023
Q3 2023 -54% -21% -62% 01 Jul 2023 30 Sep 2023
Q2 2023 -53% -27% -106% 01 Apr 2023 30 Jun 2023
Q1 2023 -49% -27% -129% 01 Jan 2023 31 Mar 2023
Q4 2022 -42% -25% -143% 01 Oct 2022 31 Dec 2022
Q3 2022 -33% -13% -65% 01 Jul 2022 30 Sep 2022
Q2 2022 -26% -2.1% -8.8% 01 Apr 2022 30 Jun 2022
Q1 2022 -21% +23% +52% 01 Jan 2022 31 Mar 2022
Q4 2021 -17% +44% +72% 01 Oct 2021 31 Dec 2021
Q3 2021 -20% +48% +70% 01 Jul 2021 30 Sep 2021
Q2 2021 -24% +45% +66% 01 Apr 2021 30 Jun 2021
Q1 2021 -44% -7.2% -20% 01 Jan 2021 31 Mar 2021
Q4 2020 -61% -13% -26% 01 Oct 2020 31 Dec 2020
Q3 2020 -68% -21% -43% 01 Jul 2020 30 Sep 2020
Q2 2020 -68% -25% -59% 01 Apr 2020 30 Jun 2020
Q1 2020 -37% +28% +44% 01 Jan 2020 31 Mar 2020
Q4 2019 -49% +4.5% +8.6% 01 Oct 2019 31 Dec 2019
Q3 2019 -47% +7.6% +14% 01 Jul 2019 30 Sep 2019
Q2 2019 -43% +16% +27% 01 Apr 2019 30 Jun 2019
Q1 2019 -65% -12% -23% 01 Jan 2019 31 Mar 2019
Q4 2018 -53% -5.1% -11% 01 Oct 2018 31 Dec 2018
Q3 2018 -55% -14% -34% 01 Jul 2018 30 Sep 2018
Q2 2018 -59% -24% -68% 01 Apr 2018 30 Jun 2018
Q1 2018 -53% -31% -146% 01 Jan 2018 31 Mar 2018
Q4 2017 -48% -18% -62% 01 Oct 2017 31 Dec 2017
Q3 2017 -41% 01 Jul 2017 30 Sep 2017
Q2 2017 -35% 01 Apr 2017 30 Jun 2017
Q1 2017 -21% 01 Jan 2017 31 Mar 2017
Q4 2016 -30% 01 Oct 2016 31 Dec 2016

Moleculin Biotech, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -90% -22% -33% 01 Jan 2024 31 Dec 2024
2023 -68% -25% -60% 01 Jan 2023 31 Dec 2023
2022 -42% -25% -143% 01 Jan 2022 31 Dec 2022
2021 -17% +44% +72% 01 Jan 2021 31 Dec 2021
2020 -61% -13% -26% 01 Jan 2020 31 Dec 2020
2019 -49% +4.5% +8.6% 01 Jan 2019 31 Dec 2019
2018 -53% -5.1% -11% 01 Jan 2018 31 Dec 2018
2017 -48% -18% -62% 01 Jan 2017 31 Dec 2017
2016 -30% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.